Association between Apolipoproteins AI and B and Ultrasound Indicators of Carotid Atherosclerosis

Zeljko Zivanovic1,2, Ivana Divjak1,2, Mirjana Jovicevic1,2

  • 1Faculty of Medicine University Novi Sad, Novi Sad, Serbia.

Insights

Apolipoprotein A-I and B levels are strongly linked to carotid atherosclerosis indicators in ischemic stroke patients. These apolipoproteins, along with the apoB/apoA-I ratio, show significant associations with ultrasound markers of disease.

Area of Science:

  • Cardiology
  • Neurology
  • Biochemistry

Background:

  • Cardiovascular and cerebrovascular disease risk may be better predicted by apolipoproteins A-I and B (apoA-I and apoB) than traditional risk factors.
  • Carotid artery atherosclerosis, detectable by ultrasound, can precede ischemic stroke (IS).
  • A carotid etiology is not present in all IS patients.

Purpose of the Study:

  • To investigate the association between ultrasound-detected carotid atherosclerosis and apolipoprotein levels in IS patients.
  • To explore the relationship between apoA-I, apoB, and other biomarkers with carotid atherosclerosis indicators.

Main Methods:

  • The study included 120 patients with a first, non-cardioembolic ischemic stroke.
  • Data collected included traditional risk factors, blood pressure, glucose, lipids, apoA-I, apoB, homocysteine, and C-reactive protein (CRP).
  • Carotid duplex ultrasound assessed intima-media thickness (cIMT) and identified unstable plaques.

Main Results:

  • Carotid intima-media thickness (cIMT) was significantly associated with older age, lower apoA-I, and a higher apoB/apoA-I ratio.
  • Unstable carotid plaque presence strongly correlated with elevated apoB, metabolic syndrome (MetS), and increased CRP levels.
  • Specific p-values and odds ratios (OR) with confidence intervals (CI) were reported for key associations.

Conclusions:

  • Apolipoprotein A-I, apoB, and the apoB/apoA-I ratio demonstrate significant associations with ultrasound markers of carotid atherosclerosis in IS patients.
  • These apolipoproteins may serve as valuable biomarkers for assessing carotid atherosclerosis in the context of ischemic stroke.
  • The findings highlight the role of specific apolipoproteins and biomarkers in the pathophysiology of carotid atherosclerosis related to stroke.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
592
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
477
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
552
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465